In addition, lowering and inhibiting ROS1 kinase, FTO protein, and lipase can reduce the incidence of metabolic syndrome in obese people, and inhibiting these receptors can also be an anti-aging approach [20,30,31]. This evidence concerns the gene FTO and metabolic syndrome.